Iron Poisoning ============== þ Suspect iron poisoning if: - Vomiting and diarrhea (especially hemorrhagic) - Hyperglycemia with metabolic acidosis during or following episodes of abdominal pain and gastroenteritis þ Iron poisoning is often classified into 4 distinct stages. Understanding the course of poisoning is important, especially the second (recovery) stage, which may lure the physician into a false sense of security and result in premature and inappropriate discharge of a patient. * Stage 1: GI o Nausea and diarrhea, often accompanied by abdominal pain, o If severe, GI hemorrhagic o fluid and blood loss, with additional third-spacing: hypovolemia or shock. o Sometimes fatal * Stage 2: Silent Phase o resolution of GI symptoms. o The patient appears to improve and recover. o Deceptive, usually occurs 6-12 hours postingestion and may last as long as 24 hours. o Metabolic abnormalities during this phase may include hypotension, metabolic acidosis, and coagulopathy. o Some patients skip this phase and progress directly to stage 3. * Stage 3: Metabolic Acidosis. o high iron concentrations produce venous pooling and third-spacing of fluids. o Elevated liver enzymes and bilirubin, coagulopathy, o Hypoglycemia may accompany liver dysfunction. o The acidosis may indicate failure of other organs, such as the heart and kidneys. * Stage 4: scarring of the healing GI tract. o The stomach and/or intestines may be affected, resulting in gastric outlet or intestinal obstruction. o weeks after a severe poisoning. þ Factors that influence iron toxicity are: * Copper Level * Phosphorus Level * Vitamin E level þ Factors that enhance iron absorption are: * Valine and Histidine * Ascorbic Acids, with or without Vitamin E * Succinate * Pyruvic Acid * Citric Acid þ Mortality much decreased from 1980 to 1990, probably due to deferoxamine treatment. þ Iron is insoluble, not excreted by liver or kidneys in significant amounts, and excretion not increased by charcoal, diuresis, or dialysis/hemoperfusion. þ Deferoxamine chelates iron and forms ferrioxamine which is renally excreted. Unlike EDTA, deferoxamine does not chelate other important metal ions. Dose: 1 gm IV not to exceed 15 mg/kg/hr (to prevent hypotension), maximum of 6 gm in 24 hours. Oral use not recommended. IM not as effective due to iron-induced hypotension. Endpoint is clinical improvement (asymptomatic for 24 hours) or normal iron levels; if iron levels not readily available, can watch urine; ferrioxamine imparts an orange-pink (vin-rose') color to urine; after urine normal color, can stop deferoxamine. In significant exposure, probably safe to use deferoxamine in pregnancy. [Curry SC, et al. An ovine model of materinal iron poisoning in pregnancy. Ann Emerg Med 1990;19:632-638.] þ Massive OD: - Vin rose urine